Cited 0 time in webofscience Cited 0 time in scopus

Liquid Chromatography and Mass Spectrometry for Biological and Clinical Analyses

Liquid Chromatography and Mass Spectrometry for Biological and Clinical Analyses
Kim, Min-Sik
DGIST Authors
Kim, Min-Sik
Issue Date
제125회 대한화학회 학술발표회
Mass spectrometry (MS) is a powerful tool to analyze small molecules and proteins in biological and clinical samples. Recently, MS has become an essential technology for an integrative multi-Omics analysis (i.e. metabolomics and proteomics are part of multi-omics along with genomics, epigenomics and transcriptomics) and large-scale proteomics experiments (Kim et al. Proteomics. 2012; Kim et al. Molecular and Cellular Proteomics. 2014.). Because of its applicability, it is now widely used for a variety of biomedical research. For example, one can discover proteome/PTM-based altered networks in perturbed biological conditions by quantitative proteomic analysis while the other could be interested in identifying potential biomarkers/therapeutic targets for diseases. I will first share my experience on a landmark experiment regarding the global human proteome mapping project by focusing on MS-based proteomics and protein modifications along with coverage of basics of MS and proteomic analysis. In addition, I will share recent proteomic results of mass spectrometry and some crucial aspects of proteomic experiments will be also discussed in the context of disease models.
Related Researcher
  • Author Kim, Min-Sik Laboratory for QBIO and Precision Medicine
  • Research Interests Cancer Proteogenomics, Biomarker Discovery, Integrative Multi-Omics
There are no files associated with this item.
Department of New BiologyLaboratory for QBIO and Precision Medicine2. Conference Papers

qrcode mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.